BioSpace News Archive

Drug Development

World Parkinson’s Day: How Science Is Battling the Disease

April 11 is World Parkinson’s Day, designed to raise awareness of Parkinson’s disease. Parkinson’s is a progressive disease of the nervous system that affects movement.

April 11, 2019
·
4 min read
·
Mark Terry
Job Trends

Fresenius Expands Manufacturing Presence in North Carolina, to Add 445 New Jobs

The German company is investing $100 million in expanding its manufacturing campus, which will add at least 445 new jobs to its current 100-plus staffing by the time it’s completed in 2022.

April 11, 2019
·
3 min read
·
Mark Terry
Business

Gilead Sciences Cuts 150 Sales Jobs After Drugs Lose Patent Protection

The loss of patent protection on two drugs is forcing Gilead Sciences to terminate about 20 percent of its sales team, according to reports.

April 11, 2019
·
2 min read
·
Alex Keown
Bio NC

AskBio Snags $235 Million Investment to Drive Gene Therapy Development

The investment, which includes $225 million from Vida Ventures and TPG, as well as $10 million from AskBio’s founders and board members, is earmarked to advance and expand clinical trials.

April 11, 2019
·
3 min read
·
Alex Keown
Drug Development

Research Roundup: Gum Disease and Alzheimer’s, a Cancer Vaccine, Cold Plasma and More

There are plenty of great scientific research stories out this week. Here’s a look at just a few of them.

April 11, 2019
·
7 min read
·
Mark Terry
Job Trends

BioSpace Movers and Shakers: April 12

Biopharma companies tap new hires to assume roles in leadership positions, with additions at Metrion, JDRF, Ribometrix, and more.

April 11, 2019
·
4 min read
·
Alex Keown
Pharm Country

Bio-Optronics® Introduces CCTrialSuite

Bio-Optronics unveiled the launch of CCTrialSuite, a comprehensive set of integrated, patient-centric clinical research management products to further streamline research operations while maintaining a high degree of compliance.

April 11, 2019
·
2 min read
Drug Development

NASH Treatments Take Center Stage at European Liver Conference

As the International Liver Conference continues to unfold in Vienna, multiple companies are presenting data on potential treatments that can address numerous needs. BioSpace takes a look at some of the data.

April 11, 2019
·
3 min read
·
Alex Keown
Drug Development

Janssen’s HIV Drug Symtuza Shows Long-Term Effect in Late Stage Trial

New data shows that patients are extremely satisfied with the medication. Data also showed that through 48 weeks, 84 percent of patients achieved undetectable viral loads, while 8 percent had virologic failures

April 11, 2019
·
2 min read
·
Alex Keown
Business

New Hampshire Sees Growth of Regenerative Manufacturing Ecosystem

The biopharma and medtech ecosystem in New Hampshire is growing thanks, in part, to state-supported tax exemptions and an increasing number of regenerative medicine manufacturing companies setting up shop in the Granite State.

April 11, 2019
·
3 min read
·
Alex Keown